Physitrack Limited · OMXSTO:PTRK

Physitrack — Q4 2024 Earnings Presentation

22 slides from Physitrack's earnings presentation, Feb 28, 2025

  1. Slide 1: Elevating the World’s Wellbeing

    Elevating the World’s Wellbeing

  2. Slide 2: Forward-looking Statement

    Forward-looking Statement This presentation contains certain forward-looking statements to differ materially from the results, or fail to meet expectations and opin- ions. Forward-looking statements are statements that expressly or implicitly assumed or described in those statements do not relate to

  3. Slide 3: Agenda

    Agenda Q4 in Short Business Updates Financial Results Strategy and Outlook Q&A Henrik Molin Charlotte Goodwin CEO & co-founder CFO

  4. Slide 4: Q4 in Short

    1.Q4 in Short

  5. Slide 5: Quarterly Progress

    Quarterly Progress Exiting Q4 with positive momentum and a unified vision for 2025 24% €0.4m Strong Revenue Growth: Revenue increased by 14% to EUR 4.2m, driven by a 14% rise in Lifecare and 13% growth in Wellness. Adjusted EBITDA margin Q4 Net cash-flow Improved Profitability: Adjusted EBITDA margi

  6. Slide 6: Business Updates

    | Business Updates

  7. Slide 7: Our two business lines positioned to capitalize on digital healthcare demand

    Our two business lines have us well-positioned to capitalize on increasing digital healthcare demand and corporate wellbeing challenges. 35% Wellness One platform, all areas of employee wellbeing Technology for employers Lifecare Seamless and efficient care solutions Technology for healthcare provid

  8. Slide 8: Lifecare Quarterly Developments

    Q42024 Lifecare Quarterly Developments Lifecare Quarterly update Continued Strong Growth: Lifecare revenue grew 14% year-on-year, with 10% annual growth overall, driven by strong recurring revenue (up 22%). The Physitrack platform saw a 39% MRR growth. 14% Churn Product Development & Innovation: Enh

  9. Slide 9: Wellness Quarterly Developments

    Q42024 Wellness Quarterly Developments YTD Revenue, Wellness segment 13% 8% €0.3m Quarterly revenue growth FY2024 recurring / 5% revenue growth which €5.6m FY2024 Adjusted now makes up 50% of EBITDA / Margin total Wellness income (FY2023: €-0.1m / 1%) Current annualised (FY2023 51%) revenue Moderate

  10. Slide 10: 2025 - Looking ahead

    2025 - Looking ahead Growth & Profitability Focus: Continued optimisation of Wellness operations to drive profitability and growth. Product Innovation: Launch of AI-powered PhysiAssistant and Physitrack patient app to enhance service offerings. Strategic Realignment: Consolidation of teams & offerin

  11. Slide 11: Financial Results

    I Financial Results

  12. Slide 12: Q4 Financial Highlights

    Q4 Financial Highlights FY2024 revenue FY2024 Subscription revenue €16.2m 10% €13.3m 18% (2023: €14.7m) (2023: €11.2m) FY2024 Adjusted EBITDA FY2024 Adjusted Cash EBITDA €3.9m/24% 12% €0.4m 597% (2023: €3.5m/24%) (2023: €0.1m) FY2024 Operating cash-flow before Anualised revenue adjusting items €3.6m

  13. Slide 13: Q4 revenue story

    | Q4 revenue story a nasa. au za a1 fosresrstes ‘Gaia comm cian ocem o1mn a2mm 2m GL GL mH GRAM GAM QUA

  14. Slide 14: Significant Growth In Subscription Revenue

    Significant Growth In Subscription Revenue

  15. Slide 15: Adjusted EBITDA

    | Adjusted EBITDA 2023.AD) EBITDA mQt saz = a3 "as 2024 AD) EBITDA EBITDA by division 48 Q4 2024 03 (1.4) 44 Q4 2023 (0.9) (20) (19) - 10 20 30 40 5.0 mLifecare Wellness = Group 60

  16. Slide 16: Cashflow

    Cashflow Available liquidity €1.6m

  17. Slide 17: Return to free-cash flow positivity

    Return to free-cash flow positivity

  18. Slide 18: Balance Sheet

    Balance Sheet 31 31 December 2024 December 2023 Euros '000 Goodwill, intangibles and PPE 26,413 34,251 Cash and cash equivalents 723 536 Borrowings (4,808) (3,578) Trade and other receivables 2,992 3,395 Trade and other payables (3,125) (2,561) Deferred revenue (2,010) (2,201) Deferred tax (595) (1,

  19. Slide 19: Strategy and Outlook

    Strategy and Outlook

  20. Slide 20: Our Unique Value Proposition

    Our Unique Value Proposition Holistic offering, powered by top-of-the-line tech True product market fit Prices in relation to the market rather than growth expectations Catering to consumer trends Improved patient outcomes through more personalized, data-driven care Positioned to capitalize on growt

  21. Slide 21: How it all comes together - Investing in Physitrack

    How it all comes together - Investing in Physitrack Market outlook and position Focus Areas High-reaching financial goals Top-line growth Physitrack aims to achieve a doubling of revenue within the medium term, replacing Growing market supported by 1. Market growth dynamics the previous target set i

  22. Slide 22: Q&A

    Q&A

Physitrack — Q4 2024 Earnings Presentation on 6ix